milrinone has been researched along with olprinone in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 11 (55.00) | 29.6817 |
| 2010's | 3 (15.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hata, H; Hata, M; Kimura, S; Obana, M; Okumura, H; Orime, Y; Sezai, A; Sezai, Y; Shiono, M; Tsukamoto, S; Yagi, S | 1 |
| Fujishima, K; Hachisu, M; Yamamoto, A | 1 |
| Baba, T; Goto, Y; Kanda, M; Noguchi, T; Nonogi, H; Sumida, H; Yasuda, S | 1 |
| Fujii, Y; Takahashi, S; Toyooka, H | 1 |
| Iribe, G; Matsunaga, A; Yamada, H; Yoshimura, N | 1 |
| Akamatsu, H; Maekawa, N; Mikawa, K; Nishina, K; Niwa, Y; Obara, H; Shiga, M | 1 |
| Furuya, H; Ishimaru, K; Kawaraguchi, Y; Kitaguchi, K; Sha, K; Shimokawa, M; Takahashi, M; Yanaidani, F | 1 |
| Fukuda, H; Hirabayashi, Y; Igarashi, T; Saitoh, K; Shimizu, R; Suzuki, H | 1 |
| Asakura, M; Asanuma, H; Fukushima, T; Hori, M; Kitakaze, M; Kuzuya, T; Liao, Y; Mori, H; Node, K; Ogai, A; Ogita, H; Papst, PJ; Sakata, Y; Sanada, S; Shinozaki, Y; Takashima, S; Terada, N; Yamada, J | 1 |
| Kanmura, Y; Matsumoto, K; Onomoto, M; Sakata, R; Suehiro, S; Tsuneyoshi, I; Yonetani, A | 1 |
| Adachi, H; Kakiki, M; Kishi, Y | 1 |
| Mizushige, K; Ueda, T | 1 |
| Sato, N | 1 |
| Goto, Y | 1 |
| Kamamoto, H | 1 |
| Iwasaki, S; Watanabe, A; Yamakage, M; Zhou, J | 1 |
| Izumi, K; Jimi, N; Mizuno, K; Sakimura, S; Sumiyoshi, R; Yoshino, J | 1 |
| Denault, AY; Gavra, P; Litalien, C; Nguyen, AQ; Theoret, Y; Varin, F | 1 |
| Dobashi, S; Fujii, T; Hisatake, S; Ikeda, T; Kabuki, T; Kiuchi, S; Nakanishi, R; Oka, T; Watanabe, I | 1 |
| Fu, Y; Pan, Y; Wang, X; Zhang, H | 1 |
4 review(s) available for milrinone and olprinone
| Article | Year |
|---|---|
The effects of olprinone, a phosphodiesterase 3 inhibitor, on systemic and cerebral circulation.
Topics: Adult; Bronchoconstriction; Cerebrovascular Circulation; Heart Rate; Humans; Imidazoles; Milrinone; Muscle, Smooth, Vascular; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridones; Splanchnic Circulation | 2006 |
[Phosphodiesterase III inhibitor--characteristics, mechanisms of action, pharmacokinetics, indications, contraindications, clinical trials, and side effects].
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Clinical Trials as Topic; Contraindications; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Pyridazines; Pyridones | 2007 |
[How to use PDE III inhibitors].
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acute Disease; Blood Pressure; Cyclic Nucleotide Phosphodiesterases, Type 3; Heart Failure; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Practice Guidelines as Topic; Pyridones; Randomized Controlled Trials as Topic | 2007 |
Systematic review and meta-analysis of the efficacy of olprinone and MEFV gene in treating heart failure.
Topics: Heart Failure; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Pyridones | 2023 |
2 trial(s) available for milrinone and olprinone
| Article | Year |
|---|---|
Effects of the phosphodiesterase III inhibitors olprinone, milrinone, and amrinone on hepatosplanchnic oxygen metabolism.
Topics: Amrinone; Analysis of Variance; Blood Gas Analysis; Cardiac Surgical Procedures; Hemodynamics; Humans; Imidazoles; Liver; Middle Aged; Milrinone; Oxygen; Phosphodiesterase Inhibitors; Postoperative Care; Prospective Studies; Pyridones; Splanchnic Circulation | 2000 |
[Differences in hemodynamic effects of amrinone, milrinone and olprinon after cardiopulmonary bypass in valvular cardiac surgery].
Topics: Aged; Amrinone; Cardiopulmonary Bypass; Female; Heart Valve Diseases; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Postoperative Care; Pyridones | 2000 |
14 other study(ies) available for milrinone and olprinone
| Article | Year |
|---|---|
Effects of phosphodiesterase inhibitors after coronary artery bypass grafting.
Topics: Aged; Cardiotonic Agents; Coronary Artery Bypass; Dobutamine; Dopamine; Female; Hemodynamics; Humans; Hypotension; Imidazoles; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Postoperative Period; Pyridones; Vasodilator Agents | 1999 |
[Effects of amrinone on renal blood flow and cardiac function, in comparison with those of milrinone and olprinone, in anesthetized dog].
Topics: Amrinone; Animals; Cardiotonic Agents; Dogs; Female; Femoral Artery; Hemodynamics; Imidazoles; Male; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridones; Renal Circulation; Vasodilator Agents | 1998 |
Diuretic effect of phosphodiesterase inhibitors depends on baseline renal function in patients with congestive heart failure.
Topics: Aged; Aged, 80 and over; Amrinone; Creatinine; Diuresis; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Kidney; Kidney Function Tests; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Pyridones; Treatment Outcome | 1999 |
The effect of olprinone compared with milrinone on diaphragmatic muscle function in dogs.
Topics: Animals; Blood Pressure; Cardiac Output; Diaphragm; Dogs; Heart Rate; Imidazoles; Milrinone; Muscle Contraction; Muscle Fatigue; Phosphodiesterase Inhibitors; Phrenic Nerve; Pulmonary Circulation; Pyridones | 1999 |
The effect of phosphodiesterase III inhibitors on human neutrophil function.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Amrinone; Calcium; Cell-Free System; Cells, Cultured; Chemotaxis, Leukocyte; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Dose-Response Relationship, Drug; Humans; Imidazoles; Milrinone; Neutrophils; Phagocytosis; Phosphodiesterase Inhibitors; Pyridones; Reactive Oxygen Species | 2000 |
Comparison of the effects of amrinone, milrinone and olprinone in reversing bupivacaine-induced cardiovascular depression.
Topics: Amrinone; Anesthetics, Local; Animals; Bupivacaine; Depression, Chemical; Dogs; Electrocardiography; Female; Hemodynamics; Imidazoles; Male; Milrinone; Phosphodiesterase Inhibitors; Pyridones; Time Factors | 2000 |
Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors: the role of protein kinase A and p38 mitogen-activated protein kinase.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Blood Flow Velocity; Bucladesine; Calcium-Calmodulin-Dependent Protein Kinases; Cardiovascular Agents; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 3; Dogs; Enzyme Inhibitors; Flavonoids; Hemodynamics; Imidazoles; Indoles; Isoquinolines; Maleimides; Milrinone; Mitogen-Activated Protein Kinases; Myocardial Infarction; p38 Mitogen-Activated Protein Kinases; Phosphodiesterase Inhibitors; Protein Kinase C; Pyridines; Pyridones; Sulfonamides; Ventricular Fibrillation | 2001 |
Differential pharmacologic sensitivities of phosphodiesterase-3 inhibitors among human isolated gastroepiploic, internal mammary, and radial arteries.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Amrinone; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Endothelium, Vascular; Gastroepiploic Artery; Humans; Imidazoles; In Vitro Techniques; Mammary Arteries; Milrinone; Phosphodiesterase Inhibitors; Pyridones; Radial Artery; Vasodilation | 2005 |
Effects of a phosphodiesterase 3 inhibitor, olprinone, on rhythmical change in tension of human gastroepiploic artery.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Amrinone; Calcium Channel Blockers; Cyclic Nucleotide Phosphodiesterases, Type 3; Diltiazem; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gastroepiploic Artery; Humans; Imidazoles; In Vitro Techniques; Milrinone; Muscle, Smooth, Vascular; Pyridones; RNA, Messenger; Time Factors; Vasodilation | 2005 |
[The effect of PDEIII inhibitors and colforsin daropate on hypoxic pulmonary vasoconstriction in rabbit lungs].
Topics: Animals; Colforsin; Hypoxia; Imidazoles; In Vitro Techniques; Male; Milrinone; Phosphodiesterase Inhibitors; Pulmonary Circulation; Pyridones; Rabbits; Vasoconstriction | 2008 |
Synergic bronchodilator effects of a phosphodiesterase 3 inhibitor olprinone with a volatile anaesthetic sevoflurane in ovalbumin-sensitised guinea pigs.
Topics: Acetylcholine; Airway Resistance; Anesthetics, Inhalation; Animals; Bronchial Hyperreactivity; Bronchoconstriction; Bronchodilator Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Guinea Pigs; Imidazoles; Lung Compliance; Male; Methyl Ethers; Milrinone; Ovalbumin; Phosphodiesterase 3 Inhibitors; Pyridones; Sevoflurane; Theophylline; Time Factors | 2011 |
[Comparison of the effects of phosphodiesterase III inhibitors, milrinone and olprinone, in infant corrective cardiac surgery].
Topics: Cardiac Surgical Procedures; Female; Heart Septal Defects, Ventricular; Hemodynamics; Humans; Hypertension, Pulmonary; Imidazoles; Infant; Intraoperative Care; Male; Milrinone; Phosphodiesterase 3 Inhibitors; Pyridones; Retrospective Studies | 2013 |
A specific and sensitive HPLC-MS/MS micromethod for milrinone plasma levels determination after inhalation in cardiac patients.
Topics: Administration, Inhalation; Cardiopulmonary Bypass; Chemical Fractionation; Chromatography, High Pressure Liquid; Heart Diseases; Humans; Hypertension, Pulmonary; Imidazoles; Milrinone; Pyridones; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Vasodilator Agents | 2014 |
Comparing the effects of milrinone and olprinone in patients with congestive heart failure.
Topics: Aged; Aged, 80 and over; Cardiotonic Agents; Disease Progression; Female; Heart Failure; Hospitalization; Humans; Imidazoles; Male; Middle Aged; Milrinone; Phosphodiesterase 3 Inhibitors; Progression-Free Survival; Pyridones; Recovery of Function; Retrospective Studies; Time Factors | 2020 |